Ansao, Rohanie M.

HRN: 26-45-94  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/21/2026
05/28/2026
IV
750mg
Q8
Psoas Abscess, S/p Drainage
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: